Document is current
Any future updates will be listed below
-
Authors
Yang, Shuo
Xie, Yan-ming
Wang, Lian-xin
-
Funding
Funding for this research was provided by:
National Key R&D Program of China (2018YFC1707400)
National Natural Science Foundation of General Program (81973982)
Fundamental Research Funds for the Central public welfare research institutes (Z0687)
- License Information
-
More Information
Article History
Received: 4 April 2023
Accepted: 13 June 2023
First Online: 20 July 2023
Declarations
:
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: The trial obtained ethical clearance from Ethics Committee of The First Affiliated Hospital of Henan University of Chinese medicine. The participants are between 2 ~ 14 years old, we will comply to the <i>World Medical Association Declaration of Helsinki</i> and <i>Good Clinical Practice of Pharmaceutical Products</i>. And we will respect the informed consent of patients fully and keep in records. All participants will be provided with verbal and printed information of this study, and written informed consent from participants (or their parent or legal guardian in the case of children under 16) is prior to participating in this study.
: Not applicable.
: The study is currently at the systematic literature review stage.
